Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

23,603 total articles

New Zscaler Report Reveals AI-Assisted Attackers Move to Massive Data Theft, Executive Targeting, and Millions in Extortion Payments

New Zscaler Report Reveals AI-Assisted Attackers Move to Massive Data Theft, Executive Targeting, and Millions in Extortion Payments

Zscaler, Inc. released its 2026 ThreatLabz Ransomware Report highlighting a 275% surge in AI-assisted ransomware attacks, resulting in 896.2 terabytes of data theft and over $328 million in ransom payments. Attackers increasingly target senior executives and exploit trusted workplace tools to facilitate data breaches and lateral movement, shifting …

Exponent Hosts Investor Day

Exponent Hosts Investor Day

Exponent, Inc. hosted an Investor Day at its Phoenix facility, showcasing its multidisciplinary expertise and growth opportunities fueled by the rise of artificial intelligence, data center infrastructure, energy sector risks, and chemicals of concern. Leadership emphasized the company's unique ecosystem of technical professionals and expanding rol…

Draganfly Announces Closing of US$10 Million Strategic Investment

Draganfly Announces Closing of US$10 Million Strategic Investment

Draganfly Inc., a leader in drone solutions, has closed a $10 million registered direct offering through the sale of common shares at $5.35 each. The proceeds will be used to accelerate advanced capability development and support working capital to meet growing demand in US and international markets. The investment was managed by Jett Capital Advis…

Namib Minerals Secures US$6.5 Million Term Loan Facility to Partially Fund Resource Definition and Bankability

Namib Minerals Secures US$6.5 Million Term Loan Facility to Partially Fund Resource Definition and Bankability

Namib Minerals (Nasdaq: NAMM) announced a new $6.5 million non-dilutive term loan facility from African Banking Corporation of Zimbabwe to partially fund the next phase of development at its Redwing Mine. The funds will be used for resource definition drilling and advancing the Definitive Feasibility Study (DFS) toward full bankability, supporting …

Accelevation Announces Pricing of Initial Public Offering

Accelevation Announces Pricing of Initial Public Offering

Accelevation Holdings Corp., a U.S.-based designer and manufacturer of customized structural, electrical, and mechanical systems for mission-critical infrastructure, has priced its initial public offering at $18 per share for 30 million shares, including a 30-day option to purchase an additional 4.5 million shares. The shares will begin trading on …

HII Wins U.S. Navy Contract for 10 ROMULUS USVs, Accelerating Deployment of Proven Autonomous Capability

HII Wins U.S. Navy Contract for 10 ROMULUS USVs, Accelerating Deployment of Proven Autonomous Capability

HII, the largest U.S. military shipbuilder and leader in autonomous seapower, won a contract to build 10 ROMULUS unmanned surface vessels for the U.S. Navy’s Medium Unmanned Surface Vessel program. This contract signals a significant step in the Navy's transition towards operational deployment of autonomous maritime technology. HII's Odyssey Autono…

DBV Technologies Announces Submission of Biologics License Application to U.S. FDA for the VIASKIN® Peanut Patch in Children Aged 4-7 Years

DBV Technologies Announces Submission of Biologics License Application to U.S. FDA for the VIASKIN® Peanut Patch in Children Aged 4-7 Years

DBV Technologies has submitted a Biologics License Application (BLA) to the U.S. FDA for the VIASKIN® Peanut Patch aimed at children aged 4-7 with peanut allergies, supported by successful Phase 3 VITESSE trial results. The company has requested Priority Review, marking a key step towards making this innovative non-invasive immunotherapy treatment …

Gain Therapeutics Announces Poster Presentation at International Congress of Parkinson’s Disease and Movement Disorders

Gain Therapeutics Announces Poster Presentation at International Congress of Parkinson’s Disease and Movement Disorders

Gain Therapeutics, a clinical-stage biotech company focused on allosteric therapies, announced a poster presentation on their lead drug candidate rexaceract at the International Congress of Parkinson's Disease and Movement Disorders. Rexaceract is a brain-penetrant small molecule in Phase 1b trials aimed at treating Parkinson's disease by restoring…

Bitdeer AI Further Expands AI Cloud Services with Off-take Commitments of more than 70% of Its 21.7MW A201 Malaysia Data Center

Bitdeer AI Further Expands AI Cloud Services with Off-take Commitments of more than 70% of Its 21.7MW A201 Malaysia Data Center

Bitdeer AI, a Nasdaq-listed AI neocloud service provider, announced it has secured off-take commitments exceeding 70% for its 21.7MW A201 data center in Johor Bahru, Malaysia, with expected revenue of $1.7 billion over five years. The liquid-cooled facility, designed for NVIDIA GB300 NVL72 and Vera Rubin deployments, is set to energize in Q1 2027. …

Farmers & Merchants Bancorp, Inc. Announces 32nd Consecutive Annual Increase in Dividend and a Special Dividend Commemorating America’s 250th Anniversary

Farmers & Merchants Bancorp, Inc. Announces 32nd Consecutive Annual Increase in Dividend and a Special Dividend Commemorating America’s 250th Anniversary

Farmers & Merchants Bancorp, Inc. (Nasdaq: FMAO) announced a 5.5% year-over-year increase in its regular quarterly dividend to $0.24 per share, along with a special $0.01 per share dividend commemorating America's 250th anniversary. This marks the company's 32nd consecutive annual dividend increase, reflecting strong financial performance and commi…

Elme Communities Provides Update On Liquidation Activities

Elme Communities Provides Update On Liquidation Activities

Elme Communities announced the completion of all remaining property sales, repayment and termination of its term loan, and declared an additional liquidating distribution of $1.74 per share, bringing total distributions to $16.41 per share. The company plans to voluntarily delist from the NYSE in early November 2026, establish a liquidating trust t…

CVRx Announces Late-Breaking Data and New Clinical Evidence on Barostim at the HFSA Annual Scientific Meeting 2026

CVRx Announces Late-Breaking Data and New Clinical Evidence on Barostim at the HFSA Annual Scientific Meeting 2026

CVRx, Inc. announced extensive presentations of new clinical data and real-world evidence on its Barostim device at the Heart Failure Society of America Annual Scientific Meeting 2026. Barostim, an FDA-approved neuromodulation implant for heart failure patients, will be featured in multiple sessions including late-breaking data from the REBALANCE R…

Saia to Announce Third Quarter 2026 Results on October 29, 2026

Saia to Announce Third Quarter 2026 Results on October 29, 2026

Saia, Inc. announced it will release its third quarter 2026 financial results before market open on October 29, 2026, followed by a conference call with management to discuss the results. The company operates in the logistics and transportation sector, providing less-than-truckload and related freight services through a network of terminals across …

Verizon Elects Charles Phillips to its Board of Directors

Verizon Elects Charles Phillips to its Board of Directors

Verizon Communications Inc. has elected Charles Phillips, a seasoned technology and finance executive, to its Board of Directors. Phillips brings extensive experience from his leadership roles in technology firms and private equity, expected to contribute to Verizon's innovation, customer satisfaction, and long-term shareholder value.

Pyxis Oncology Announces Proposed Public Offering

Pyxis Oncology Announces Proposed Public Offering

Pyxis Oncology, a clinical-stage biopharmaceutical company specializing in therapeutics for hard-to-treat cancers, announced a registered public offering of common stock, pre-funded warrants, and accompanying common warrants. Proceeds will fund the advancement of its lead antibody-drug conjugate (MICVO) through key clinical milestones including a p…